Regeneron Pharmaceuticals Inc. (REGN) Declined -6.07% or -22.3 To Price $345.39 On Wednesday


Regeneron Pharmaceuticals Inc. (REGN) declined -6.07% or -22.3 to $345.39. It is close to 1.39 million shares traded, which is 189.1% compare to the average total volume 735992. The market cap of REGN is $37.74 billion. The year to date change is -7.34%. The 52 week price range is from $281.89 to $442.0. Price of REGN have changed -9.93% during last week. It have changed -9.79% over last month, -9.11% over last 3 months, -7.74% over last 6 months and 15.55% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for REGN is 410.49. It is 18.85% above current price. The 200-day Moving Averages for REGN is 386.21. It is 11.82% above current price. The 52-week High is 442.0. It is 27.97% from the current price. The 52-week Low is 281.89. It is -18.39% from current price.

There are some statistics of REGN. It is has market cap $37.74 billion. The share outstanding is 109.28 million. The average volume is 735992. The percent of top 15 Institution holding is 108.70%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of REGN is 33.40%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of REGN is 24.29%.


Tags:

Share this post